Topography-guided LASIK Surgery
A Prospective Evaluation of Topography-guided LASIK Surgery
1 other identifier
interventional
30
1 country
1
Brief Summary
The investigators are analyzing outcomes of topography-guided LASIK surgery in participants with myopia and myopic astigmatism
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 18, 2017
CompletedFirst Posted
Study publicly available on registry
September 25, 2017
CompletedStudy Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2022
CompletedApril 5, 2022
April 1, 2022
3.1 years
September 18, 2017
April 3, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Epithelial thickness maps
Changes in anterior segment optical coherence tomography epithelial thickness maps.
12 months
Secondary Outcomes (7)
Changes in corrected visual acuity
12 months
Uncorrected distance visual acuity
12 months
Quality of Vision
12 months
Predictability
12 months
Contrast visual acuity
12 months
- +2 more secondary outcomes
Study Arms (1)
Topography guided LASI
OTHERInterventions
Eligibility Criteria
You may qualify if:
- Subjects age 18 and older with healthy eyes. Nearsightedness between -0.50 diopters and -8.00 diopters.
- Subjects with up to 3.00 diopters of astigmatism.
- Subjects with a spherical equivalent of up to -9.00 diopters.
You may not qualify if:
- Subjects under the age of 18.
- Subjects with excessively thin corneas.
- Subjects with topographic evidence of keratoconus.
- Subjects with ectatic eye disorders.
- Subjects with autoimmune diseases.
- Subjects who are pregnant or nursing.
- Subjects with more than 3.00 diopters of astigmatism
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Byers Eye Institute at Stanford
Palo Alto, California, 94303, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Edward E Manche, MD
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- N0ne
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Ophthalmology
Study Record Dates
First Submitted
September 18, 2017
First Posted
September 25, 2017
Study Start
June 1, 2018
Primary Completion
June 30, 2021
Study Completion
March 31, 2022
Last Updated
April 5, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share